Free Trial
ASX:MSB

Mesoblast (MSB) Stock Price, News & Analysis

Mesoblast logo

About Mesoblast Stock (ASX:MSB)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
10.19 million shs
Average Volume
N/A
Market Capitalization
A$2.32 billion
P/E Ratio
N/A
Dividend Yield
2.58%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MSB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesoblast and its competitors with MarketBeat's FREE daily newsletter.

MSB Stock News Headlines

This Could Be the Most Profitable Season of Your Life
Institutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the same point in every cycle when crypto enters its most explosive phase — and two experts are showing how to ride it. Inside The Crypto Code Workshop, you’ll get their step-by-step system and $10 in free Bitcoin for attending.
See More Headlines

MSB Stock Analysis - Frequently Asked Questions

Mesoblast Limited (ASX:MSB) posted its quarterly earnings data on Thursday, February, 21st. The company reported ($0.09) earnings per share for the quarter. Mesoblast had a negative trailing twelve-month return on equity of 17.79% and a negative net margin of 1,490.27%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mesoblast investors own include Mesoblast (MESO), Fortescue (FMG), MicroStrategy (MSTR), Aus Tin Mining (ANW), OceanaGold (OGC), Piedmont Lithium (PLL) and Alliance Resource Partners (ARLP).

Company Calendar

Last Earnings
2/21/2019
Today
7/18/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
Trading
Current Symbol
ASX:MSB
CIK
N/A
Fax
N/A
Employees
83
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.13)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
9.56
Net Income
-A$87.96 million
Net Margins
-1,490.27%
Pretax Margin
N/A
Return on Equity
-17.79%
Return on Assets
-5.41%

Debt

Debt-to-Equity Ratio
24.76
Current Ratio
1.18
Quick Ratio
1.82

Sales & Book Value

Annual Sales
A$5.90 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
30.00
Book Value
A$0.43 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,140,000,000
Free Float
N/A
Market Cap
A$2.32 billion
Optionable
Not Optionable
Beta
2.38
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (ASX:MSB) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners